« Catholic Democrats Issue Letter Defending Pro-Abortion Stance | Main | Latin America Is Falling Apart And Nobody Cares! »
March 1, 2006
Scented Underarm Antiperspirants May Increase Breast Cancer Risk
Topics: MedicineUnderarm antiperspirants may contribute to the risk of breast cancer because they contain aluminum salts with metal ions that mimic the effect of estrogen. Until recently, it was thought that such estrogen-mimicking substances were uniformly organic, either phenolic or carbon ring structures. However, according to Philippa Darbre, Ph.D., of the University of Reading, evidence is mounting that some metals can also binding to estrogen receptors.
The underarm connection arises from the fact that aluminum -- which, as aluminum salts, comprises up to 25% of some antiperspirants -- appears to be one of those estrogen-mimicking metals. It joins a growing list of so-called "metalloestrogens," including antimony, arsenite, barium, cadmium, chromium, cobalt, copper, lead, mercury, nickel, selenite, tin, and vanadate.
A range of substances, most of them organic, have been shown to mimic estrogen, and may increase the risk of breast cancer. This review suggests that metal ions, including those derived from the aluminum salts in antiperspirants, may have similar effects, although more research is needed to identify the specific risks.
Posted by Richard at March 1, 2006 10:54 PM
Articles Related to Medicine:
- Monitor Your Moles For Signs Of Dangerous Skin Cancer - Apr 28, 2008
- Compound Found In Soybeans May Halt Spread Of Prostate Cancer - Apr 01, 2008
- Fewer Doses Of Radiation Still Effective In Beating Breast Cancer - Mar 19, 2008
- Severe Psychological Stress May Be Linked To Breast Cancer - Mar 10, 2008
- Scientists Say Anti-Cancer Smart Bomb Ready For Human Use - Mar 05, 2008
- New Research Confirms The Power Of Images In The Brain To Heal The Body - Jan 07, 2008
- Genentech's Avastin Shows Promise In Brain Cancer - Nov 18, 2007
- Synthetic Molecule Makes Cancer Cells Commit Suicide - Nov 14, 2007
- New Targeted Approach To Light-Activated Cancer Drugs With Tumor-Seeking Antibodies Shows Promise - Nov 10, 2007
- Study Suggests New Pill Is Better Than Traditional Chemotherapy - Oct 09, 2007


















